Presentation is loading. Please wait.

Presentation is loading. Please wait.

Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility 

Similar presentations


Presentation on theme: "Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility "— Presentation transcript:

1 Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility  Iris M. Otani, MD, William R. Lumry, MD, Shelley Hurwitz, PhD, Huamin Henry Li, MD, PhD, Timothy J. Craig, DO, Niki S. Holtzman, BA, Matthew I. Iandoli, MS, Julie Tucker, CCRC, Marc A. Riedl, MD, MS, Bruce L. Zuraw, MD, Aleena Banerji, MD  The Journal of Allergy and Clinical Immunology: In Practice  Volume 5, Issue 2, Pages e1 (March 2017) DOI: /j.jaip Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Figure 1 Time in minutes from attack onset to A, treatment and B, complete symptom resolution was significantly shorter for self-administration compared with HCP-administration. Data presented as mean with SD. ***P < **P < .01. The Journal of Allergy and Clinical Immunology: In Practice 2017 5, e1DOI: ( /j.jaip ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Figure E1 A, Visual Analogue Score (VAS) and B, Patient Symptom Score (PSS). The Journal of Allergy and Clinical Immunology: In Practice 2017 5, e1DOI: ( /j.jaip ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions


Download ppt "Subcutaneous Icatibant for the Treatment of Hereditary Angioedema Attacks: Comparison of Home Self-Administration with Administration at a Medical Facility "

Similar presentations


Ads by Google